The Misuse of Drugs Act 1971 (Modification) (No. 2) Order 2003
| Year | 2003 |
2003 No. 3201
DANGEROUS DRUGS
The Misuse of Drugs Act 1971 (Modification) (No. 2) Order 2003
Made 10th December 2003
Coming into force 29th January 2004
At the Court at Buckingham Palace, the 10th day of December 2003
Present,
The Queen’s Most Excellent Majesty in Council
Whereas a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and has been approved by a resolution of each House of Parliament;
Now, therefore, Her Majesty, in pursuance of section 2(2) of the Misuse of Drugs Act 19711, is pleased, by and with the advice of Her Privy Council, to order, and it is hereby ordered, as follows:—
1. This Order may be cited as the Misuse of Drugs Act 1971 (Modification) (No. 2) Order 2003 and shall come into force on 29th January 2004.
2.—(1) Schedule 2 to the Misuse of Drugs Act 19712(which specifies the drugs which are subject to control under that Act) shall be amended as follows.
(2) In paragraph 1(a) of Part I of that Schedule, “Cannabinol, except where contained in cannabis or cannabis resin” and “Cannabinol derivatives” shall be deleted.
(3) In paragraph 1(a) of Part II of that Schedule, “Cannabis and cannabis resin” shall be deleted.
(4) In paragraph 1(a) of Part III of that Schedule, there shall be inserted after “Camazepam”, “Cannabinol”, “Cannabinol derivatives” and “Cannabis and cannabis resin”.
(5) In paragraph 1(d) of Part III of that Schedule, there shall be inserted after “above”, “or of cannabinol or a cannabinol derivative”.
A. K. Galloway
Clerk of the Privy Council
(This note is not part of the Order)
This Order reclassifies four substances in Schedule 2 to the Misuse of Drugs Act 1971 which specifies drugs which are subject to control under the Act. The four substances, cannabinol and cannabinol derivatives (previously Class A drugs) and cannabis and cannabis resin (previously Class B drugs), are reclassified as Class C drugs. In addition, any substance which is an ester or ether either of cannabinol or of a cannabinol derivative (previously a Class A drug) is reclassified as a Class C drug.
To continue reading
Request your trial